N. T. Yucel Et Al. , "Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain," PSYCHOPHARMACOLOGY , vol.237, no.4, pp.1131-1145, 2020
Yucel, N. T. Et Al. 2020. Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain. PSYCHOPHARMACOLOGY , vol.237, no.4 , 1131-1145.
Yucel, N. T., CAN, Ö. D., & Ozkay, U. D., (2020). Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain. PSYCHOPHARMACOLOGY , vol.237, no.4, 1131-1145.
Yucel, Nazli, ÖZGÜR DEVRİM CAN, And Umide Demir Ozkay. "Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain," PSYCHOPHARMACOLOGY , vol.237, no.4, 1131-1145, 2020
Yucel, Nazli T. Et Al. "Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain." PSYCHOPHARMACOLOGY , vol.237, no.4, pp.1131-1145, 2020
Yucel, N. T. CAN, Ö. D. And Ozkay, U. D. (2020) . "Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain." PSYCHOPHARMACOLOGY , vol.237, no.4, pp.1131-1145.
@article{article, author={Nazli Turan Yucel Et Al. }, title={Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain}, journal={PSYCHOPHARMACOLOGY}, year=2020, pages={1131-1145} }